Skip to main content

Advertisement

SpringerLink
Log in

Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-d-Phel-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide

  • Letters to the editor
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bangard M, Behe M, Guhlke S, Otte R, Bender H, Maecke HR, Biersack HJ. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide. Eur JNucl Med 2000; 27: 628–637.

    Article  CAS  Google Scholar 

  2. Maecke HR, Behe M. New octreotide derivatives labelled with technetium-99m [abstract]. J Nucl Med 1996; 37: 29P.

    Google Scholar 

  3. Decristoforo C, Mather SJ. Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence. Eur J Nucl Med 1999; 26: 869–876.

    Article  CAS  PubMed  Google Scholar 

  4. Decristoforo C, Melendez-Alafort L, Sosabowski JK, Mather SJ. 99mTc-HYNIC-[Tyr3]-octreotide for imaging SST-receptor positive tumours, preclinical evaluation and comparison with 111In-octreotide. J Nucl Med 2000; 41:1114–1119.

    CAS  PubMed  Google Scholar 

  5. Decristoforo C, Mather SJ, Cholewinski W, Donnemiler E, Riccabona G, Moncayo R. 99mTc-EDDA/HYNIC-TOC — a new technetium-99m labelled radiopharmaceutical for imaging somatostatin receptor positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives. Eur J Nucl Med 2000; 27 (in press).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäts Klinik für Nuklearmedizin, Anichstrasse 35, 6020, Innsbruck, Austria

    C. Decristoforo, W. Cholewinski, E. Donnemiller, G. Riccabona & R. Moncayo

  2. Nuclear Medicine Research Laboratory, St. Bartholomew's Hopital, London, UK

    S.J. Mather

Authors
  1. C. Decristoforo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Cholewinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Donnemiller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Riccabona
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Moncayo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S.J. Mather
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Decristoforo, C., Cholewinski, W., Donnemiller, E. et al. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-d-Phel-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide. Eur J Nucl Med 27, 1580 (2000). https://doi.org/10.1007/s002590000354

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002590000354

Search

Navigation